Cim Investment Management Inc. bought a new stake in shares of Rocket Lab Corporation (NASDAQ:RKLB – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,761 shares of the rocket manufacturer’s stock, valued at approximately $1,399,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Gordian Capital Singapore Pte Ltd purchased a new position in Rocket Lab in the fourth quarter worth $29,000. Reflection Asset Management purchased a new stake in shares of Rocket Lab during the 4th quarter valued at $30,000. Meeder Asset Management Inc. acquired a new stake in shares of Rocket Lab in the 2nd quarter worth $30,000. Highland Investment Advisors LLC acquired a new stake in shares of Rocket Lab in the 2nd quarter worth $30,000. Finally, NBH Bank purchased a new position in Rocket Lab during the 2nd quarter worth $30,000. Hedge funds and other institutional investors own 71.78% of the company’s stock.
Rocket Lab Stock Performance
RKLB stock traded down $2.49 during trading on Tuesday, hitting $69.70. 18,577,986 shares of the company traded hands, compared to its average volume of 23,070,619. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00. The company has a market cap of $41.70 billion, a PE ratio of -258.14 and a beta of 2.60. The stock’s 50-day simple moving average is $69.55 and its 200 day simple moving average is $84.41. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.
Insider Activity
In related news, insider Frank Klein sold 35,558 shares of the stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $66.61, for a total transaction of $2,368,518.38. Following the sale, the insider directly owned 925,737 shares of the company’s stock, valued at approximately $61,663,341.57. This represents a 3.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the sale, the insider owned 458,924 shares in the company, valued at approximately $31,954,878.12. This represents a 3.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 3,536,371 shares of company stock valued at $303,442,641 in the last three months. Corporate insiders own 8.40% of the company’s stock.
More Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Iridium shareholders approved Rocket Lab’s acquisition with approximately 99.6% of votes cast in favor, moving the roughly $8 billion transaction closer to an expected mid-2027 closing. The deal would add Iridium’s satellite network and more than 2.5 million subscribers, providing Rocket Lab with recurring communications revenue alongside its launch and space-systems businesses. Rocket Lab Bounces Off Its Lows—What’s Behind the Move?
- Positive Sentiment: Rocket Lab completed additional successful Electron missions, including back-to-back September launches for Synspective, reinforcing its launch reliability and customer demand. The company also continues to benefit from expectations that SpaceX may reduce third-party rideshare availability beginning in 2028, potentially improving demand and pricing power for alternative providers. Rocket Lab Nails Back-to-Back September Launches
- Positive Sentiment: Analyst sentiment remains favorable, with recently cited price targets generally well above the current trading range. ARK Invest and several institutional investors have also increased their Rocket Lab positions, supporting the long-term growth narrative around Electron, Neutron and defense contracts.
- Neutral Sentiment: SpaceX’s Starship reached orbit and deployed 26 satellites, but an engine issue shortened the mission and the vehicle was destroyed during splashdown. The event highlights stronger launch competition while also potentially benefiting Rocket Lab if SpaceX prioritizes its own constellation and limits rideshare capacity. Starship’s Weak Spot Could Help Rocket Lab and Firefly
- Negative Sentiment: Rocket Lab raised approximately $1.944 billion through an at-the-market offering, issuing about 29.3 million shares to help finance the Iridium transaction. Additional shares under the cash-and-stock structure, along with Iridium’s amended term loan, have kept dilution and post-merger balance-sheet risks in focus.
- Negative Sentiment: Reported insider activity shows 97 sales and no purchases over the past six months, including substantial selling by executives. While insider sales can reflect personal financial planning, the one-sided pattern may weigh on investor confidence. Rocket Lab also remains unprofitable, and the still-unlaunched Neutron rocket remains a critical execution test.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on RKLB shares. Roth Capital set a $110.00 target price on Rocket Lab in a research report on Tuesday, August 11th. Cantor Fitzgerald reissued an “overweight” rating on shares of Rocket Lab in a report on Monday, September 21st. Citizens Jmp restated a “market outperform” rating and set a $130.00 price target on shares of Rocket Lab in a research note on Tuesday, August 11th. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a report on Friday, July 17th. Finally, Raymond James Financial initiated coverage on shares of Rocket Lab in a research report on Friday, September 11th. They issued an “outperform” rating and a $80.00 price objective for the company. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $107.32.
Get Our Latest Stock Report on Rocket Lab
Rocket Lab Profile
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
Featured Articles
- Five stocks we like better than Rocket Lab
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB – Free Report).
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
